Click the link above to view the Etoricoxib (Arcoxia) gout study.
This review is published as:
- Title:
- Questions and Answers on the Review of Etoricoxib-Containing Medicines.
- Authors:
- European Medicines Agency (EMEA)
- Published:
- June 2008
This gout review recommends:
- Etoricoxib should continue to be licensed for short term acute gout and other conditions.
- Doctors must be aware of heart and blood pressure risks before and during treatment.
As with all forms of gout pain relief, long term risks associated with anti-inflammatory drugs need to be avoided. You should only take pain relief for a few months until you get uric acid down to safe levels.
I describe the best way to control gout in my gout treatment guidelines.
Leave Review of Etoricoxib (Arcoxia) to browse the Gout Treatment Guidelines
